{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:32:09Z","timestamp":1789421529282,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07761-1","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:57:13Z","timestamp":1773370633000},"page":"4794-4802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenges and unmet needs of\u00a0[18F]fluorocholine PET in hyperparathyroidism: A framework for refining current practice and\u00a0advancing parathyroid imaging"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-3292","authenticated-orcid":false,"given":"Martin W.","family":"Huellner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza K.","family":"Isenschmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Petranovi\u0107 Ov\u010dari\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert-Ram","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"Deandreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire B.","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Eigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Liberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giovanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"9","key":"7761_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12149-020-01507-1","volume":"34","author":"L Evangelista","year":"2020","unstructured":"Evangelista L, Ravelli I, Magnani F, Iacobone M, Giraudo C, Camozzi V, et al. 18F-choline PET\/CT and PET\/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature. Ann Nucl Med. 2020;34(9):601\u201319.","journal-title":"Ann Nucl Med"},{"issue":"2","key":"7761_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ando.2015.03.026","volume":"76","author":"JO Prior","year":"2015","unstructured":"Prior JO. New scintigraphic methods for parathyroid imaging. Ann Endocrinol (Paris). 2015;76(2):145\u20137.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"7761_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-019-0544-3","volume":"9","author":"WAM Broos","year":"2019","unstructured":"Broos WAM, Wondergem M, Knol RJJ, Van Der Zant FM. Parathyroid imaging with 18F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res. 2019;9(1):72.","journal-title":"EJNMMI Res"},{"issue":"9","key":"7761_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/RLU.0000000000003738","volume":"46","author":"T Hofer","year":"2021","unstructured":"Hofer T, Kronbichler J, Huber H, Hergan B, Kaiser B, Shamiyeh A, et al. 18F-Choline PET\/CT, MRI, and software-based image fusion analysis in patients with primary hyperparathyroidism. Clin Nucl Med. 2021;46(9):710\u20136.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"7761_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00259-017-3920-0","volume":"45","author":"A Imperiale","year":"2018","unstructured":"Imperiale A, Ta\u00efeb D, Hindi\u00e9 E. 18F-fluorocholine PET\/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism. Eur J Nucl Med Mol Imaging. 2018;45(4):654\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7761_CR6","doi-asserted-by":"crossref","unstructured":"Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh Q-Y, Vriens MR, et al. 18\u2009F fluorocholine PET\/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: A prospective pilot Study. Radiology. 2017;284(2):460\u20137.","DOI":"10.1148\/radiol.2016160768"},{"issue":"11","key":"7761_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.21037\/gs-22-198","volume":"11","author":"M Manyalich-Blasi","year":"2022","unstructured":"Manyalich-Blasi M, Dom\u00ednguez-Garijo P, Saavedra-P\u00e9rez D, S\u00e1nchez-Izquierdo N, Casanueva Eliceiry S, Perissinotti A, et al. Comparison of [18F]fluorocholine PET\/CT with [99mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study. Gland Surg. 2022;11(11):1764\u201371.","journal-title":"Gland Surg"},{"issue":"1","key":"7761_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-023-02893-6","volume":"408","author":"M Noltes","year":"2023","unstructured":"Noltes M, Rotstein L, Eskander A, Kluijfhout W, Bongers P, Brouwers AH, et al. 18F-fluorocholine PET\/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas. Langenbecks Arch Surg. 2023;408(1):155.","journal-title":"Langenbecks Arch Surg"},{"issue":"12","key":"7761_CR9","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1097\/RLU.0000000000001845","volume":"42","author":"N Thanseer","year":"2017","unstructured":"Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, et al. Comparative effectiveness of ultrasonography, 99mTc-sestamibi, and 18F-fluorocholine PET\/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med. 2017;42(12):e491\u20137.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"7761_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","volume":"46","author":"G Treglia","year":"2019","unstructured":"Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751\u201365.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7761_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07373-1","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2025","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Schaab J, Beintner-Skawran S, Maurer A, Rupp NJ, Ikenberg K, et al. [18F]fluorocholine pet\/MRI and [18F]fluorocholine pet\/CT as first- and second-line imaging in primary hyperparathyroidism \u2013 who takes the lead? Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07373-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7761_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-023-00553-8","volume":"10","author":"G Verfaillie","year":"2023","unstructured":"Verfaillie G, Franck C, De Crop A, Beels L, D\u2019Asseler Y, Bacher K. A systematic review and meta-analysis on the radiation dose of computed tomography in hybrid nuclear medicine imaging. EJNMMI Phys. 2023;10(1):32.","journal-title":"EJNMMI Phys"},{"key":"7761_CR13","doi-asserted-by":"crossref","unstructured":"Isenschmid SK, Schaab JA, Gennari AG, Inoue Inukai J, Morand GB, Mueller SA, et al. MR pulse sequences for parathyroid adenoma imaging using [18F]fluorocholine PET\/MR in primary hyperparathyroidism. Nuclear Medicine and Molecular Imaging; 2025.","DOI":"10.1007\/s13139-025-00961-x"},{"issue":"6","key":"7761_CR14","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s00330-017-5190-4","volume":"28","author":"GF Huber","year":"2018","unstructured":"Huber GF, H\u00fcllner M, Schmid C, Brunner A, Sah B, Vetter D, et al. Benefit of 18F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol. 2018;28(6):2700\u20137.","journal-title":"Eur Radiol"},{"issue":"1","key":"7761_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-025-00244-w","volume":"9","author":"A Mamou","year":"2025","unstructured":"Mamou A, Chkair S, Gilly O, Maimoun L, Mamou Y, Sheppard SC, et al. Economic evaluation of [18F]fluorocholine PET\/CT in pre operative assessment of hyperfunctional parathyroids in primary hyperparathyroidism: a cost effectiveness analysis. EJNMMI Rep. 2025;9(1):11.","journal-title":"EJNMMI Rep"},{"issue":"12","key":"7761_CR16","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00259-024-06771-1","volume":"51","author":"S Van Mossel","year":"2024","unstructured":"Van Mossel S, Saing S, Appelman-Dijkstra N, Quak E, Schepers A, Smit F, et al. Cost-effectiveness of one-stop-shop [18F]Fluorocholine PET\/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism. Eur J Nucl Med Mol Imaging. 2024;51(12):3585\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7761_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.surg.2021.03.075","volume":"171","author":"A Yap","year":"2022","unstructured":"Yap A, Hope TA, Graves CE, Kluijfhout W, Shen WT, Gosnell JE, et al. A cost-utility analysis of 18F-fluorocholine\u2013positron emission tomography imaging for localizing primary hyperparathyroidism in the United States. Surgery. 2022;171(1):55\u201362.","journal-title":"Surgery"},{"key":"7761_CR18","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE-H, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research. 2020;37(11):2293\u2009\u2013\u2009314.","DOI":"10.1002\/jbmr.4677"},{"issue":"8","key":"7761_CR19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/hed.25023","volume":"40","author":"BC Stack Jr","year":"2018","unstructured":"Stack BC Jr., Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, et al. AHNS series: do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: definitive multidisciplinary joint consensus guidelines of the American head and neck society and the British association of endocrine and thyroid surgeons. Head Neck. 2018;40(8):1617\u201329.","journal-title":"Head Neck"},{"issue":"8","key":"7761_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00423-015-1348-1","volume":"400","author":"M Barczy\u0144ski","year":"2015","unstructured":"Barczy\u0144ski M, Br\u00e4nstr\u00f6m R, Dionigi G, Mihai R. Sporadic multiple parathyroid gland disease\u2014a consensus report of the European society of endocrine surgeons (ESES). Langenbecks Arch Surg. 2015;400(8):887\u2013905.","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"7761_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00423-015-1348-1","volume":"400","author":"M Barczynski","year":"2015","unstructured":"Barczynski M, Branstrom R, Dionigi G, Mihai R. Sporadic multiple parathyroid gland disease\u2013a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2015;400(8):887\u2013905.","journal-title":"Langenbecks Arch Surg"},{"issue":"5","key":"7761_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.20945\/2359-3997000000556","volume":"66","author":"NE Cusano","year":"2022","unstructured":"Cusano NE, Cetani F. Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab. 2022;66(5):666\u201377.","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"7761_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00423-019-01782-1","volume":"404","author":"E Trebouet","year":"2019","unstructured":"Trebouet E, Bannani S, Wargny M, Leux C, Caillard C, Kraeber-Bodere F, et al. Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate. Langenbecks Arch Surg. 2019;404(4):431\u20138.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"7761_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.23736\/S1824-4785.23.03513-6","volume":"67","author":"JN Talbot","year":"2023","unstructured":"Talbot JN, Perie S, Tassart M, Delbot T, Aveline C, Zhang-Yin J, et al. 18F-fluorocholine PET\/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET\/CTs in one center. Q J Nucl Med Mol Imaging. 2023;67(2):96\u2013113.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"7761_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.remnie.2024.500066","volume":"44","author":"F Garcia Garcia","year":"2025","unstructured":"Garcia Garcia F, Cassinello Fernandez N, Rodriguez Romera J, Marti Fernandez R, Lapena Rodriguez M, Alfonso Ballester R, et al. PET-TC [(18)F]F-choline and intraoperative PTH in the surgical treatment of the primary hyperparathyroidism without preoperative location. Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition). 2025;44(1):500066.","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"},{"issue":"1","key":"7761_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejso.2016.09.016","volume":"43","author":"M Hocevar","year":"2017","unstructured":"Hocevar M, Lezaic L, Rep S, Zaletel K, Kocjan T, Sever MJ, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with (18)F-Fluorocholine PET\/CT. Eur J Surg Oncol. 2017;43(1):133\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"7761_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1442972","volume":"15","author":"L Hargitai","year":"2024","unstructured":"Hargitai L, Boryshchuk D, Arikan M, Binter T, Scheuba C, Riss P. Is intraoperative parathyroid monitoring during minimally invasive parathyroidectomy still justified? Front Endocrinol (Lausanne). 2024;15:1442972.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7761_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111873","volume":"183","author":"GJR Cook","year":"2025","unstructured":"Cook GJR, Alberts IL, Wagner T, Fischer BM, Nazir MS, Lilburn D. The impact of long axial field of view (LAFOV) PET on oncologic imaging. Eur J Radiol. 2025;183:111873.","journal-title":"Eur J Radiol"},{"key":"7761_CR29","doi-asserted-by":"crossref","unstructured":"Holman BF, Willson T, Edwards J, Ferreira B, Wijewickrama P, Wagner T. [(18)F]-fluorocholine long-axial-field of view PET-CT accurately localises intrathyroid parathyroid adenoma in 5-month pregnant patient. Eur J Nucl Med Mol Imaging. 2025.","DOI":"10.1007\/s00259-025-07417-6"},{"issue":"7","key":"7761_CR30","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/RLU.0000000000005735","volume":"50","author":"D Denizmen Zorba","year":"2025","unstructured":"Denizmen Zorba D, Kuyumcu S, Kubat Uzum A, Isik EG, Sanli Y. Detection of recurrent parathyroid cancer using 68Ga-Trivehexin PET\/CT. Clin Nucl Med. 2025;50(7):e451-2.","journal-title":"Clin Nucl Med"},{"issue":"13","key":"7761_CR31","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1007\/s00259-024-06846-z","volume":"51","author":"S Kuyumcu","year":"2024","unstructured":"Kuyumcu S, Denizmen D, Has-Simsek D, Poyanli A, Uzum AK, Buyukkaya F, et al. (68)Ga-Trivehexin PET\/CT: a promising novel tracer for primary hyperparathyroidism. Eur J Nucl Med Mol Imaging. 2024;51(13):3912\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7761_CR32","doi-asserted-by":"crossref","unstructured":"Filippi L, Bianconi F, Ferrari C, Linguanti F, Battisti C, Urbano N et al. Digital versus analogue PET in parathyroid imaging: comparison of PET metrics and machine learning-based characterisation of hyperfunctioning lesions (the DIGI-PET study). Eur J Nucl Med Mol Imaging. 2025.","DOI":"10.1007\/s00259-025-07508-4"},{"issue":"4","key":"7761_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2478\/raon-2022-0037","volume":"56","author":"L Jarabek","year":"2022","unstructured":"Jarabek L, Jamsek J, Cuderman A, Rep S, Hocevar M, Kocjan T, et al. Detection and localization of hyperfunctioning parathyroid glands on [(18)F]fluorocholine PET\/ CT using deep learning - model performance and comparison to human experts. Radiol Oncol. 2022;56(4):440\u201352.","journal-title":"Radiol Oncol"},{"issue":"2","key":"7761_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/EJE-22-0206","volume":"187","author":"P Sandqvist","year":"2022","unstructured":"Sandqvist P, Sundin A, Nilsson I-L, Gryb\u00e4ck P, Sanchez-Crespo A. Primary hyperparathyroidism, a machine learning approach to identify multiglandular disease in patients with a single adenoma found at preoperative Sestamibi-SPECT\/CT. Eur J Endocrinol. 2022;187(2):257\u201363.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"7761_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110191","volume":"51","author":"K Shen","year":"2025","unstructured":"Shen K, Tan M, Liu Y, Xu X, Yang S. From data to diagnosis: how artificial intelligence is revolutionizing preoperative assessment of thyroid nodules and cancer. Eur J Surg Oncol. 2025;51(9):110191.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"7761_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.23736\/S1824-4785.20.03227-6","volume":"66","author":"P Alongi","year":"2022","unstructured":"Alongi P, Laudicella R, Stefano A, Caobelli F, Comelli A, Vento A, et al. Choline PET\/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study. Q J Nucl Med Mol Imaging. 2022;66(4):352\u201360.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"7761_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14121264","author":"L Urso","year":"2024","unstructured":"Urso L, Cittanti C, Manco L, Ortolan N, Borgia F, Malorgio A, et al. ML models built using clinical parameters and radiomic features extracted from (18)F-choline PET\/CT for the prediction of biochemical recurrence after metastasis-directed therapy in patients with oligometastatic prostate cancer. Diagnostics. 2024. https:\/\/doi.org\/10.3390\/diagnostics14121264.","journal-title":"Diagnostics"},{"issue":"10","key":"7761_CR38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.ultrasmedbio.2024.05.026","volume":"50","author":"W Zhou","year":"2024","unstructured":"Zhou W, Zhou Y, Zhang X, Huang T, Zhang R, Li D, et al. Development and validation of an explainable machine learning model for identification of Hyper-Functioning parathyroid glands from High-Frequency ultrasonographic images. Ultrasound Med Biol. 2024;50(10):1506\u201314.","journal-title":"Ultrasound Med Biol"},{"issue":"9","key":"7761_CR39","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Giovanella L, Carri\u00f3 Gasset I, Hindi\u00e9 E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10116","key":"7761_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism Lancet. 2018;391(10116):168\u201378.","journal-title":"Hyperparathyroidism Lancet"},{"issue":"2","key":"7761_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115\u201325.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"7761_CR42","first-page":"e158","volume":"168","author":"G Cocchiara","year":"2017","unstructured":"Cocchiara G, Fazzotta S, Palumbo VD, Damiano G, Cajozzo M, Maione C, et al. The medical and surgical treatment in secondary and tertiary hyperparathyroidism. Rev Clin Ter. 2017;168(2):e158\u201367.","journal-title":"Rev Clin Ter"},{"issue":"1","key":"7761_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-025-01234-6","volume":"15","author":"W Jitrapinate","year":"2025","unstructured":"Jitrapinate W, Raruenrom Y, Wongsurawat N, Sa-Ngiamwibool P, Theerakulpisut D. SPECT\/CT in addition to subtraction parathyroid scintigraphy in hyperparathyroidism: diagnostic performance in a cohort of predominantly end-stage renal disease patients. EJNMMI Res. 2025;15(1):34.","journal-title":"EJNMMI Res"},{"issue":"1","key":"7761_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11154-017-9421-4","volume":"18","author":"MR Portillo","year":"2017","unstructured":"Portillo MR, Rodr\u00edguez-Ortiz ME. Secondary hyperparthyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies. Rev Endocr Metab Disord. 2017;18(1):79\u201395.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"7761_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-023-00548-5","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu Y, Li N, Xu K, Zhang W. Quantitative application of dual-phase 99mTc-sestamibi SPECT\/CT imaging of parathyroid lesions: identification of optimal timing in secondary hyperparathyroidism. EJNMMI Phys. 2023;10(1):29.","journal-title":"EJNMMI Phys"},{"issue":"41","key":"7761_CR46","doi-asserted-by":"publisher","first-page":"e1701","DOI":"10.1097\/MD.0000000000001701","volume":"94","author":"L Michaud","year":"2015","unstructured":"Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, et al. A pilot comparison of 18F-fluorocholine PET\/CT, ultrasonography and 123I\/99mTc-sestaMIBI Dual-Phase Dual-Isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Med (Baltim). 2015;94(41):e1701.","journal-title":"Med (Baltim)"},{"issue":"6","key":"7761_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/j.semnuclmed.2024.08.002","volume":"54","author":"L Noskovicova","year":"2024","unstructured":"Noskovicova L, Balogova S, Aveline C, Tassart M, Zhang-Yin J, Kerrou K, et al. (18)F-Fluorocholine-positron emission tomography\/computerized tomography (FCH PET\/CT) imaging for detecting abnormal parathyroid glands: indication, practice, interpretation and diagnostic performance. Semin Nucl Med. 2024;54(6):875\u201395.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"7761_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00268-008-9894-0","volume":"33","author":"ND Perrier","year":"2009","unstructured":"Perrier ND, Edeiken B, Nunez R, Gayed I, Jimenez C, Busaidy N, et al. A novel nomenclature to classify parathyroid adenomas. World J Surg. 2009;33(3):412\u20136.","journal-title":"World J Surg"},{"key":"7761_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-025-02105-9","author":"JI Inukai","year":"2025","unstructured":"Inukai JI, Sah B-R, Beintner-Skawran S, Maurer A, Mueller SA, Morand GB, et al. Use of the tracheal bisecting line to differentiate upper pole from lower pole parathyroid adenomas: a PET\/MR study using [18F]fluorocholine. Ann Nucl Med. 2025. https:\/\/doi.org\/10.1007\/s12149-025-02105-9.","journal-title":"Ann Nucl Med"},{"issue":"5","key":"7761_CR50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1148\/rg.2020190190","volume":"40","author":"PM Bunch","year":"2020","unstructured":"Bunch PM, Randolph GW, Brooks JA, George V, Cannon J, Kelly HR. Parathyroid 4D CT: what the surgeon wants to know. Radiographics. 2020;40(5):1383\u201394.","journal-title":"Radiographics"},{"issue":"11","key":"7761_CR51","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/RLU.0000000000004814","volume":"48","author":"JN Talbot","year":"2023","unstructured":"Talbot JN, Perie S, Tassart M, Safa JB, Montravers F, Balogova S. The presence of an arteria lusoria should be checked when reporting 18 F-FCH PET\/CT performed to localize hyperfunctioning parathyroid glands. Clin Nucl Med. 2023;48(11):958\u20139.","journal-title":"Clin Nucl Med"},{"issue":"36","key":"7761_CR52","doi-asserted-by":"publisher","first-page":"e44342","DOI":"10.1097\/MD.0000000000044342","volume":"104","author":"A Gohar","year":"2025","unstructured":"Gohar A, Ahmad MH, Masroor M, Ali M, Ayman A, Usman A, et al. A presentation of brown tumor in a patient with parathyroid adenoma and end-stage renal disease: a case report. Med. 2025;104(36):e44342.","journal-title":"Med"},{"issue":"03","key":"7761_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-0042-1751031","volume":"21","author":"WAM Broos","year":"2022","unstructured":"Broos WAM, Knol RJJ, Zant FMVD, Schaper NC, Wondergem M. Incidental findings on 18F-Fluorocholine PET\/CT for parathyroid imaging. World J Nucl Med. 2022;21(03):192\u20139.","journal-title":"World J Nucl Med"},{"issue":"11","key":"7761_CR54","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/MNM.0000000000001887","volume":"45","author":"H Gr\u00fcnig","year":"2024","unstructured":"Gr\u00fcnig H, Strobel K, Zander A, P\u00e9rez Lago MDS, Lima T, Wicke C, et al. Significance of incidental thyroid 18F-fluorocholine uptake in patients with hyperparathyroidism imaged for localizing hyperfunctioning parathyroid glands. Nucl Med Commun. 2024;45(11):938\u201346.","journal-title":"Nucl Med Commun"},{"key":"7761_CR55","doi-asserted-by":"crossref","unstructured":"Ortega-Serrano J, Serrano-L\u00f3pez S, Alfonso-Ballester R, Mart\u00ed-Fern\u00e1ndez R, Lape\u00f1a-Rodr\u00edguez M, Exp\u00f3sito RD, et al. Is the 18F-choline PET-CT more cost-effective than standard protocol for locating a parathyroid adenoma? Langenbecks Arch Surg. 2025;410(1):235.","DOI":"10.1007\/s00423-025-03824-3"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07761-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07761-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07761-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:03:12Z","timestamp":1781002992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07761-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7761"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07761-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"P.P.O. and L.G. serve as editorial board members at EJNMMI.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}